The aim of the SYNTAX II trial was to compare PCI using first-generation drug-eluting stents with CABG surgery for patients with complex coronary artery disease.
On Monday 11th September 2017, a panel of experts in the field met in London to discuss the results of the trial.
Dr. Justin Davies (London, United Kingdom)
Prof Javier Escaned (Madrid, Spain)
Prof Amir Lerman (Minnesota, USA)
Prof Bruce Samuels (Los Angeles, USA)
Dr Andrew Sharp (Exeter, UK)
• To increase awareness of the key outcomes from Syntax II
• To discuss the data in wider historical context
• To discuss clinical implications of this data
• To summarise and debate future research to be conducted as a result of Syntax II